---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-002472"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:46:47.229866+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NYSE American accepts VolitionRx compliance plan; shares continue trading until Aug 2027 review

## Summary
- Received non-compliance notice on Feb 6, 2026 for stockholders' equity deficiency (below $2M threshold).
- Compliance plan submitted by March 8, 2026; accepted by NYSE American on April 22, 2026.
- Company has until August 6, 2027 to regain compliance; subject to periodic NYSE American review.
- If plan progress insufficient or compliance not met by deadline, delisting proceedings may be initiated.
- No immediate impact on listing; common stock continues trading under symbol VNRX on NYSE American.

## SEC filing metadata
- accession: 0001477932-26-002472
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793226002472/0001477932-26-002472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793226002472/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-002472
- JSON: https://secwatch.observer/filing/0001477932-26-002472.json
- Plain text: https://secwatch.observer/filing/0001477932-26-002472.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.